Clinical Trials Directory

Trials / Conditions / Pustular Psoriasis

Pustular Psoriasis

6 registered clinical trials studyying Pustular Psoriasis.

StatusTrialSponsorPhase
CompletedEvaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.
NCT07428941
AI Labs Group S.L—
CompletedSpecial Drug Use-results Survey to Evaluate Safety and Efficacy of Cosentyx in Pediatric Patients With PsV, Ps
NCT05215561
Novartis Pharmaceuticals—
CompletedInfliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis)
NCT03885089
Pfizer—
CompletedAn Efficacy and Safety Study of CNTO1959 (Guselkumab) in the Treatment of Participants With Generalized Pustul
NCT02343744
Janssen Pharmaceutical K.K.Phase 3
UnknownObservational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
NCT01952275
University of Zurich—
CompletedAnakinra for Inflammatory Pustular Skin Diseases
NCT01794117
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Phase 2